References
- Hutchinson TA, Flegel KM, Kramer MS, et al, Frequency, severity and risk factors for adverse drug reactions in adult outpatients: a prospective study. J Chronic Dis 1986; 39:533-42. https://doi.org/10.1016/0021-9681(86)90198-0
- Beijer HJ, de Blaey CJ. Hospitalizations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci 2002; 24: 46-54. https://doi.org/10.1023/A:1015570104121
- Pirmohamed M, James S, Meakin S, et al, Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients. Br Med J 2004; 329: 15-9. https://doi.org/10.1136/bmj.329.7456.15
- El Desoky ES. Pharmacokinetic-pharmacodynamic crisis in the elderly. Am J Ther 2007; 14: 488-98. https://doi.org/10.1097/01.mjt.0000183719.84390.4d
- McLean AJ, Le Couteur DG. Aging biology and geriatric clinical pharmacology. Pharmacol Rev 2004; 56: 163-84. https://doi.org/10.1124/pr.56.2.4
- American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for Potentially inappropriate medication use in older adults. J Am Geriatr Soc 2012; 60: 616-31. https://doi.org/10.1111/j.1532-5415.2012.03923.x
-
National Committee on Quality Assurance.
$ HEDIS^{(R)}$ 2012 Final NDC lists: use of high-risk medications in the elderly (DAE). Washington, DC: 2012. Available from: http://www. NCQA.org/HEDISQualityMeasurement/HEDISMeasures/ HEDIS2012/HEDIS2012FinalNDC Lists.aspx. [accessed 2012 November 2]. - Waller PC, Coulson RA, Wood SM. Regulatory pharmacovigilance in the United Kingdom: current principles and practice. Pharmacoepidemiol Drug Saf 1996; 5: 363-75. https://doi.org/10.1002/(SICI)1099-1557(199611)5:6<363::AID-PDS249>3.0.CO;2-7
- KFDA. The 13th KFDA statistics annual report, 2011. Available from: http://www.kfda.go.kr/index.kfda?searchkey =title:contents&mid=97&searchword=annualreport&cd=&p ageNo=1&seq=12217&cmd=v. [accessed 2012 November 17]
- Evans SJ, Waller PC, Davis S. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf 2001; 10: 483-6. https://doi.org/10.1002/pds.677
- Egberts AC, Meyboom RH, van Puijenbroek EP. Use of measures of disproportionality in pharmacovigilance: three Dutch examples. Drug Saf 2002; 25: 453-8. https://doi.org/10.2165/00002018-200225060-00010
- Lindquist M, Ståhl M, Bate A, et al, A retrospective evaluation of a data mining approach to aid finding new adverse drug reaction signals in the WHO international database. Drug Saf 2000; 23: 533-42. https://doi.org/10.2165/00002018-200023060-00004
- Korean society for pharmacoepidemiology and risk management. Pharmacoepidemiology, 1st ed. Seoul: Seoul national university press, 2011: 65-8, 323.
- Shalviri G, Mohammad K, Majdzadeh R, et al, Applying quantitiative methods for detecting new drug safety signals in pharmacovigilance national database. Pharmacoepidemiol Drug Saf 2007; 16: 1136-40. https://doi.org/10.1002/pds.1459
- Van Puijenbroek EP, Bate A, Leufkens HG, et al, A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol Drug Saf 2002; 11: 3-10. https://doi.org/10.1002/pds.668
- KFDA. Drug use pattern and evaluation for appropriateness in Geriatric patients. 2004. Available from: http://dl.nanet. go.kr/OpenFlashViewer.do [accessed 2012 November 20].
- Christiansen C. X-ray contrast media: an overview. Toxicology. 2005; 209: 185-7. https://doi.org/10.1016/j.tox.2004.12.020
- Shin MJ, Cho YJ. Management of adverse reaction to iodinated radio contrast media. J Korean Med Assoc 2012; 55: 779-90. https://doi.org/10.5124/jkma.2012.55.8.779
- Budnitz DS, Lovegrove MC, Shehab N, et al, Emergency Hospitalizations for adverse drug Events in older Americans. N Engl J Med 2011; 65: 2002-12.